2026 Southeast Asia Enzymes Export Strategy White Paper

The Great Contraction: A Platform-Specific Crisis

For Southeast Asian enzyme manufacturers, the data from Alibaba.com paints a concerning picture. Between 2023 and 2025, the trade amount for this category has seen a consistent year-over-year decline, with a particularly sharp drop of over 30% in 2025. This downturn is mirrored in buyer behavior: the number of active buyers (AB count) and the AB rate—a key indicator of marketplace health—have both contracted significantly during the same period. On the surface, this suggests a waning global appetite for enzymes. However, this conclusion would be a dangerous misreading of the true market dynamics at play.

Trade volume for Southeast Asian enzyme suppliers on Alibaba.com declined by over 30% YoY in 2025.

The supply side tells a similar story of retreat. The average number of products per supplier (average product AB count) has also plummeted, indicating that many sellers are either reducing their offerings or exiting the platform altogether. This collective pullback creates a negative feedback loop: fewer products lead to less visibility, which attracts fewer buyers, further discouraging suppliers. Yet, this narrative of decline is confined to the digital B2B marketplace. It does not reflect the reality of the global industry.

The Global Growth Engine: A Market in Expansion

Contrary to the platform's contraction, the global food and feed enzymes market is in a phase of vigorous expansion. According to a comprehensive report by Grand View Research, the global food enzymes market is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2030 ^[1]. This growth is fueled by rising consumer demand for processed foods, clean-label trends, and the need for efficient food production. Similarly, the feed enzymes market is even more dynamic, with MarketsandMarkets forecasting a CAGR of 6.5% between 2024 and 2029 ^[2]. The primary driver here is the surging global demand for animal protein, which pushes the livestock industry to seek cost-effective and sustainable ways to enhance feed conversion ratios, with enzymes being a key solution.

The global feed enzymes market is driven by the need to optimize feed costs and meet the growing demand for meat, dairy, and eggs, especially in emerging economies ^[2].

This stark contrast—the platform's contraction versus the global market's expansion—creates a powerful paradox. It suggests that the problem is not a lack of global opportunity, but a failure of a specific group of suppliers (Southeast Asian exporters on this platform) to effectively connect with that opportunity. The question then becomes: what is blocking this connection?

The Regulatory Chasm: Why the Bridge is Broken

The answer lies in the complex and stringent regulatory landscapes of the world's most lucrative markets: the United States and the European Union. For any enzyme to be used in food or animal feed in these regions, it must undergo a rigorous safety assessment and receive formal approval. In the US, the Food and Drug Administration (FDA) governs this process. Food enzymes are typically regulated as food additives or as substances that are 'Generally Recognized As Safe' (GRAS). Achieving GRAS status, whether through a self-determination or a formal FDA notification, requires extensive scientific data on the enzyme's purity, origin, and safety ^[3].

Similarly, in the European Union, the European Food Safety Authority (EFSA) is responsible for evaluating the safety of feed and food additives, including enzymes. Before an enzyme can be placed on the market, it must be included in the EU's positive lists, which requires a lengthy and costly application process involving detailed dossiers on its manufacturing process, toxicology, and efficacy ^[4]. For many small and medium-sized enterprises (SMEs) in Southeast Asia, navigating these regulatory mazes is a daunting, resource-intensive, and often prohibitively expensive endeavor. Without these certifications, their products are effectively barred from the largest and most profitable segments of the global market.

Key Regulatory Requirements for Major Markets

Market	Governing Body	Key Requirement	Primary Challenge for ASEAN Suppliers
United States	FDA	GRAS status or Food Additive Petition	Cost and complexity of scientific dossier preparation
European Union	EFSA	Inclusion in EU Positive Lists	Lengthy approval timeline and high administrative burden

The lack of these certifications is the primary reason why Southeast Asian suppliers are unable to compete for the high-value contracts that drive global market growth, leading to their apparent decline on the B2B platform.

A Beacon of Hope: The ASEAN Success Story

The situation is not without hope. The existence of successful Southeast Asian players in this space proves that the barrier can be overcome. Companies like Aumax Bio, a Thailand-based biotechnology firm, have managed to build a global business in animal nutrition and feed enzymes ^[5]. Their success is not accidental; it is built on a foundation of strategic investment in R&D, a deep understanding of international regulatory frameworks, and a commitment to quality that meets or exceeds global standards. They serve as a living case study for other ASEAN manufacturers, demonstrating that with the right approach, the regional industry can be a formidable global competitor.

Strategic Roadmap for 2026: From Compliance to Competitive Advantage

For Southeast Asian enzyme exporters looking to reverse their fortunes in 2026, the path forward is clear but challenging. It requires a shift in focus from simply listing products online to building a robust, compliance-driven export strategy. The following roadmap provides a practical framework for action:

1. Prioritize Target Markets and Certifications: Instead of a scattergun approach, manufacturers should strategically select one or two key markets (e.g., the US or EU) and dedicate resources to obtaining the necessary certifications (GRAS or EFSA approval). This focused effort is more likely to yield results than trying to be everywhere at once.

2. Invest in R&D and Quality Control: Building a strong scientific dossier for regulatory submissions requires a solid foundation in R&D. Investment in strain improvement, fermentation optimization, and downstream processing will not only support certification but also create higher-quality, more effective products that command premium prices.

3. Forge Strategic Partnerships: Collaborating with established distributors, contract research organizations (CROs), or regulatory consultants in target markets can significantly de-risk the entry process. These partners bring invaluable local knowledge, established networks, and experience in navigating complex regulatory environments.

4. Leverage Regional Trade Agreements: ASEAN has various free trade agreements (FTAs) with global partners. Understanding and utilizing these agreements can provide tariff advantages and facilitate smoother market entry once the primary regulatory hurdles are cleared.

By adopting this strategic, long-term view, Southeast Asian enzyme manufacturers can transform the current challenge into a powerful competitive advantage. The global market is waiting; the key is to build the bridge that connects their production capabilities to the world's demand.